Zopolrestat

Overview

Zopolrestat is an inhibitor of Aldose Reductase(AR). It has been shown to play roles in inflammation and cancer. It is used for the treatment of diabetic nephropathy and cardiac disease. It was developed by Pfizer and was terminated in clinic phase 2 trials.

Application

Products > Drug Discovery > Inhibitor | Products > Drug Discovery > Inhibitor | Endocrinology and Metabolic Disease | Aldose Reductase

Product Information

• Catalog No.: B0084-358923
• CAS No.: 110703-94-1
• Molecular Formula: C19H12F3N3O3S
• Molecular Weight: 419.38
• Purity: 95%
• Storage: 2-8°C
• Solubility: DMSO: ≥20 mg/mL

Source

Original product source